Computational Pathology Market, By Technology (Deep Learning and Neural Networks, Machine Learning (Non-Deep Learning), Computer Vision and Image Processing, and Cloud Computing and Edge Computing), By Product Type, By Workflow Stage, By Deployment Mode, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4795
|
Published Date
November 2025
|
Pages
365
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Computational Pathology Market size was valued at US$ 650.98 Million in 2024, expanding at a CAGR of 9.30% from 2025 to 2032.
Computational Pathology refers to an advanced digital platform that supports healthcare organizations and pathologists by automating diagnostic, analytical, and operational tasks. Leveraging technologies such as artificial intelligence (AI), machine learning (ML), and image recognition, these systems analyze digital pathology slides to detect patterns, quantify biomarkers, and generate actionable insights.
Computational pathology enhances diagnostic accuracy, reduces human error, and streamlines laboratory workflows, enabling faster turnaround times for test results. By automating routine processes such as image segmentation, annotation, and data analysis, it minimizes manual effort while improving overall laboratory efficiency. Additionally, these solutions provide precise, data-driven insights that support clinical decision-making, helping pathologists and clinicians make informed treatment choices. Beyond diagnostics, computational pathology facilitates the expansion of digitally enabled and accessible pathology services, promoting improved patient outcomes and supporting large-scale research initiatives in healthcare. Its integration into modern laboratories represents a significant step toward efficient, accurate, and scalable pathology workflows in both clinical and research settings.
Computational Pathology Market- Market Dynamics
Rising Adoption of Digital Pathology Platforms
Rising Adoption of Digital Pathology Platforms refers to the growing implementation of advanced digital systems that enable pathologists and healthcare organizations to efficiently manage, analyze, and share pathology data. These platforms integrate high-resolution pathology imaging, AI algorithms, and analytical tools within laboratory and clinical workflows, enhancing diagnostic accuracy and operational efficiency. In computational pathology, they facilitate automated image analysis, real-time data interpretation, and quantitative evaluation of tissue samples, allowing pathologists to generate faster insights, reduce manual workload, and improve overall diagnostic performance.
Integration with laboratory information systems (LIS) and electronic health records (EHRs) ensures seamless data flow and interoperability, while continuous AI model training through data-driven feedback enhances diagnostic precision over time. Overall, the adoption of digital pathology platforms strengthens the scalability, reliability, and effectiveness of computational pathology solutions in modern healthcare systems. For example, a September2025 study published in Frontiers in Digital Health on digital pathology adoption in Jordan reported that 69.2% of surveyed pathologists had average or above-average knowledge of digital pathology, and 85% expressed willingness to use digital pathology tools for diagnostics if available. These findings underscore strong professional readiness and interest in expanding digital pathology solutions, highlighting a sustained trend toward integrating digital technologies to improve diagnostics, research, remote access, and education in healthcare settings.
Computational Pathology Market- Segmentation Analysis:
The Global Computational Pathology Market is segmented on the basis of Technology, Product Type, Workflow Stage, Deployment Mode, End User, and Region.
The Computational Pathology market is commonly segmented by Workflow Stage into Pre-Analytical, Analytical, and Post-Analytical stages. The Analytical stage holds a significant market share due to its critical role in enabling accurate AI-driven image analysis, efficient pathology interpretation, and timely diagnostic reporting. Diagnostic reporting involves documenting and communicating medical test results, such as pathology findings, in a clear and structured format to guide clinical decision-making and patient care. Optimizing the analytical workflow enhances image interpretation, accelerates diagnostic processes, and ensures timely and accurate results. Increased efficiency at this stage improves diagnostic accuracy, reduces pathologist workload, and allows laboratories to process more samples effectively. In computational pathology, Analytical-stage efficiency is achieved through AI-driven image interpretation, automated quantification of tissue features, and rapid report generation, helping pathologists validate and finalize findings quickly while minimizing manual errors. For example, a 2025 study published in PNAS Nexus demonstrated that a compact convolutional neural network achieved a diagnostic classification accuracy (AUC) of approximately 0.87 in differentiating normal lymph nodes from various lymphoma subtypes using standard histological images, illustrating the strong potential of AI-powered computational pathology tools in clinical applications.
The market is also segmented by Technology into AI-Based Technologies and Image Analysis & Visualization Technologies. The AI-Based Technologies segment accounts for a substantial portion of the market due to its ability to enhance diagnostic accuracy, scalability, and analytical efficiency. Scalability in AI-based solutions refers to the capability of algorithms to process large volumes of pathology images efficiently while maintaining consistent performance, allowing laboratories to expand diagnostic capacity without proportionally increasing manual effort or infrastructure complexity. AI-driven technologies support automated image analysis, pattern recognition, and quantitative assessment of tissue samples at scale, enabling faster diagnoses, reduced pathologist workload, and continuous improvement through data-driven learning. For instance, the UK government’s Artificial Intelligence Sector Study 2024 reported that the country’s AI ecosystem grew significantly between 2023 and 2024, with total AI sector revenue increasing by approximately 68% and AI-related employment rising to 86,139 jobs. This growth highlights rapid adoption of AI technologies across industries, including healthcare, and underscores the increasing maturity of digital pathology infrastructure. Overall, AI-based computational pathology solutions are enabling scalable, interoperable, and data-driven diagnostic workflows, supporting accurate, efficient, and reliable clinical decision-making across healthcare and research settings.
Computational Pathology Market- Geographical Insights
The Computational Pathology market exhibits significant regional variation, driven by differences in healthcare infrastructure, digital pathology adoption, and regulatory frameworks. North America remains the leading market, fueled by advanced diagnostic facilities, early adoption of AI-based pathology solutions, strong research ecosystems, and high utilization rates in the U.S. and Canada. Europe is experiencing steady growth, supported by increasing investments in precision diagnostics, favorable regulatory guidance for digital pathology, and the expanding integration of AI across pathology workflows. The Asia Pacific region is rapidly emerging, driven by accelerated healthcare digitalization, rising cancer prevalence, growing AI investments, and supportive government initiatives in countries such as China, India, Japan, and South Korea. Meanwhile, Latin America, the Middle East, and Africa are gradually developing, with market growth supported by improvements in laboratory infrastructure, increasing awareness of computational pathology tools, and initiatives to enhance diagnostic efficiency, accessibility, and quality across healthcare systems.
United States Healthcare Virtual Assistant Market – Country Insights
The U.S. Computational Pathology market is experiencing steady growth, driven by an advanced healthcare infrastructure and the increasing adoption of AI-enabled diagnostic technologies. Hospitals, pathology laboratories, and research institutions are implementing computational pathology solutions to enhance diagnostic accuracy, streamline laboratory workflows, and support precision medicine initiatives. The market growth is further reinforced by active engagement from leading technology providers, digital pathology solution companies, and research organizations, alongside supportive regulatory frameworks for AI-based diagnostics. Additionally, growing emphasis on operational efficiency, standardized diagnostic outcomes, and data-driven clinical decision-making is accelerating adoption across healthcare facilities.
For instance, according to IntuitionLabs’ AI in Hospitals: 2025 Adoption Trends & Statistics report, by 2024, approximately 71% of non-federal acute-care hospitals in the U.S. had integrated predictive AI solutions with electronic health record (EHR) systems, up from 66% in 2023, demonstrating rapid AI adoption in hospital settings. During the same period, 66% of U.S. physicians reported using AI-based tools in clinical practice in 2024, representing a 78% increase compared to 2023. These figures underscore the expanding role of AI in supporting clinical decision-making, diagnostics, and operational efficiency across U.S. healthcare institutions.
Computational Pathology Market- Competitive Landscape:
The Computational Pathology market is moderately concentrated, with several leading medical imaging, digital pathology, and AI-focused healthcare technology companies shaping the competitive landscape. Key players include Roche Diagnostics, Philips Healthcare, Siemens Healthineers, GE Healthcare, Leica Biosystems, Hamamatsu Photonics, Olympus Corporation, 3DHISTECH, Indica Labs, PathAI, Paige AI, Proscia, Visiopharm, Aiforia Technologies, and Ibex Medical Analytics. These companies compete by providing advanced AI-driven solutions for whole slide imaging, image analysis, tumor detection, biomarker quantification, and diagnostic decision support.
For example, in 2024, Proscia enhanced its Concentriq AP platform by expanding cloud-enabled digital pathology workflows and supporting multi-AI model integration. This allows pathologists to access insights from multiple AI algorithms within a unified environment, improving slide analysis speed, diagnostic consistency, and collaboration across distributed laboratory networks. The market is propelled by rising demand for precise diagnostics, automated workflows, and precision medicine applications, particularly in oncology and biomedical research. Proscia and similar providers are also advancing their platforms through deeper integration with laboratory information systems (LIS), regulatory-compliant software updates, scalable cloud infrastructure, and AI-driven image analytics, addressing the evolving needs of pathology laboratories, hospitals, and research institutions seeking efficient, reliable, and data-centric solutions.
Recent Developments:
- In 2025, Roche received Breakthrough Device Designation from the U.S. FDA for its VENTANA TROP2 RxDx computational pathology companion diagnostic, reinforcing its leadership in AI-driven precision oncology. Simultaneously, PathAI launched a multi-year collaboration with Northwestern Medicine to implement its AISight image management system, aimed at enhancing diagnostic accuracy, workflow efficiency, and consistency across clinical pathology operations. These initiatives highlight the growing impact of computational pathology on clinical decision-making and demonstrate how strategic partnerships and regulatory support are driving next-generation diagnostic solutions.
- Also in 2025, PathAI expanded FDA clearance for its AISight® Dx digital pathology image management system to include additional whole-slide scanners through a Predetermined Change Control Plan (PCCP). This made AISight® Dx one of the first AI/ML pathology platforms to secure this regulatory pathway, improving interoperability, enabling broader lab adoption, and supporting scalable implementation in diverse pathology environments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL COMPUTATIONAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- LeicaBiosystemsNusslochGmbH
- HamamatsuPhotonicsK.K
- KoninklijkePhilipsN.V.
- F.HoffmannLaRocheLtd.
- Aiforia Technologies PLC
- Epredia
- Visiopharm A/S
- Proscia Inc.
- Mindpeak GmbH
- Others
GLOBALCOMPUTATIONAL PATHOLOGY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Deep Learning and Neural Networks
- Machine Learning (Non-Deep Learning)
- Computer Vision and Image Processing
- Cloud Computing and Edge Computing
- Predictive and Prescriptive Analytics
- Big Data and HighPerformance Computing (HPC)
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Software
- Services
- Hardware
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032
- PreAnalytical
- Analytical
- PostAnalytical
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY DEPLOYMENT MODE - MARKET ANALYSIS, 2019 - 2032
- OnPremises
- CloudBased
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals and Diagnostic Laboratories
- Biotechnology & Pharmaceutical Companies
- Research Institutes and Academic Centers
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Computational Pathology Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Computational Pathology Market Snippet by Technology
2.1.2. Computational Pathology Market Snippet by Product Type
2.1.3. Computational Pathology Market Snippet by Workflow Stage
2.1.4. Computational Pathology Market Snippet by Deployment Mode
2.1.5. Computational Pathology Market Snippet by End User
2.1.6. Computational Pathology Market Snippet by Country
2.1.7. Computational Pathology Market Snippet by Region
2.2. Competitive Insights
3. Computational Pathology Key Market Trends
3.1. Computational Pathology Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Computational Pathology Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Computational Pathology Market Opportunities
3.4. Computational Pathology Market Future Trends
4. Computational Pathology Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Computational Pathology Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Computational Pathology Market Landscape
6.1. Computational Pathology Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Computational Pathology Market – By Technology
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
7.1.2. Deep Learning and Neural Networks
7.1.3. Machine Learning (Non-Deep Learning)
7.1.4. Computer Vision and Image Processing
7.1.5. Cloud Computing and Edge Computing
7.1.6. Predictive and Prescriptive Analytics
7.1.7. Big Data and HighPerformance Computing (HPC)
8. Computational Pathology Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
8.1.2. Software
8.1.3. Services
8.1.4. Hardware
9. Computational Pathology Market – By Workflow Stage
9.1. Overview
9.1.1. Segment Share Analysis, By Workflow Stage, 2024&2032 (%)
9.1.2. PreAnalytical
9.1.3. Analytical
9.1.4. PostAnalytical
10. Computational Pathology Market – By Deployment Mode
10.1. Overview
10.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
10.1.2. OnPremises
10.1.3. CloudBased
11. Computational Pathology Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
11.1.2. Hospitals and Diagnostic Laboratories
11.1.3. Biotechnology & Pharmaceutical Companies
11.1.4. Research Institutes and Academic Centers
12. Computational Pathology Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Computational Pathology Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Computational Pathology Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Computational Pathology Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APACMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.5. APACMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.6. APACMarket Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.7. APACMarket Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.8. APACMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. PhilippinesMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.4. PhilippinesMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.5. PhilippinesMarket Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.16.6. PhilippinesMarket Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.16.7. PhilippinesMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Computational Pathology Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.5.8. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Computational Pathology Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Computational Pathology Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. LeicaBiosystemsNusslochGmbH
13.2.2. HamamatsuPhotonicsK.K
13.2.3. KoninklijkePhilipsN.V.
13.2.4. F.HoffmannLaRocheLtd.
13.2.5. Aiforia Technologies PLC
13.2.6. Epredia
13.2.7. Visiopharm A/S
13.2.8. Proscia Inc.
13.2.9. Mindpeak GmbH
13.2.10. Others
14. 360 Degree AnalystView
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL COMPUTATIONAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- LeicaBiosystemsNusslochGmbH
- HamamatsuPhotonicsK.K
- KoninklijkePhilipsN.V.
- F.HoffmannLaRocheLtd.
- Aiforia Technologies PLC
- Epredia
- Visiopharm A/S
- Proscia Inc.
- Mindpeak GmbH
- Others
GLOBALCOMPUTATIONAL PATHOLOGY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Deep Learning and Neural Networks
- Machine Learning (Non-Deep Learning)
- Computer Vision and Image Processing
- Cloud Computing and Edge Computing
- Predictive and Prescriptive Analytics
- Big Data and HighPerformance Computing (HPC)
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Software
- Services
- Hardware
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032
- PreAnalytical
- Analytical
- PostAnalytical
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY DEPLOYMENT MODE - MARKET ANALYSIS, 2019 - 2032
- OnPremises
- CloudBased
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals and Diagnostic Laboratories
- Biotechnology & Pharmaceutical Companies
- Research Institutes and Academic Centers
GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
